Hypertensive vascular remodeling was inhibited by Xuezhikang through the regulation of Fibulin-3 and MMPs in spontaneously hypertensive rats
- PMID: 25932142
- PMCID: PMC4402789
Hypertensive vascular remodeling was inhibited by Xuezhikang through the regulation of Fibulin-3 and MMPs in spontaneously hypertensive rats
Abstract
Fibulin-3, an extracellular glycoprotein, has been suggested as having functions in vessels. In hypertension, extracellular matrix, matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) play important roles in cardiovascular remodeling. However, the role of Fibulin-3 as an extracellular glycoprotein in hypertensive vascular remodeling remains unclear. Our study was to determine whether Fibulin-3 and TIMPs/MMPs would affect vascular structure during hypertension and the treatment of Xuezhikang. Thirty spontaneously hypertensive rats (SHRs) aged 8 weeks were randomized to three groups: SHRs control group (SHRs group, n=10), group treated with low dose Xuezhikang (XZK-L, 20 mg/kg/d, n=10) and group treated with high dose Xuezhikang (XZK-H, 200 mg/kg/d, n=10), the normal group was comprised of ten Wistar-Kyoto (WKY) rats of the same age. We showed that serum nitric oxide (NO) in control group was significantly lower than WKY group (P<0.05). Concomitantly, serum oxidized low-density lipoprotein (ox-LDL) was higher than WKY group (P<0.05). The treatment of high dose Xuezhikang significantly dicreased ox-LDL, left ventricular mass index (LVMI) and Wall-to-lumen area ratio (W/L) of thoracic aorta (P<0.05), while serum NO was significantly increasing (P<0.05). Moreover, the expressions of Fibulin-3 and MMP-2, 9 at both protein and mRNA levels were significantly higher in thoracic aorta of SHRs group compared to WKY group by immunohistochemistry and western blotting (P<0.05). However, the levels of Fibulin-3 and MMP-2, 9 were significantly decreased in XZK-H group compared to control group (P<0.05). The level of TIMP-3 had no significance difference between SHRs and WKY groups (P>0.05). So the levels of Fibulin-3 and MMP-2, 9 in SHRs could be inhibited by Xuezhikang. Furthermore, a strong correlation in transcript expression was established between Fibulin-3, and MMP-2 (r=0.81, P<0.05) and MMP-9 (r=0.92, P<0.05) through immunohistochemistry. In summary, the overexpression of Fibulin-3 and MMP-2, 9 levels were associated with hypertension and vascular remodeling and inhibited by Xuezhikang. Fibulin-3 is a candidate in the pathogenesis of cardiovascular remodeling in hypertension.
Keywords: Fibulin-3; hypertension; matrix metalloproteinase; spontaneously hypertensive rat; vascular remodeling.
Figures




Similar articles
-
Fibulin-3 may improve vascular health through inhibition of MMP-2/9 and oxidative stress in spontaneously hypertensive rats.Mol Med Rep. 2016 May;13(5):3805-12. doi: 10.3892/mmr.2016.5036. Epub 2016 Mar 21. Mol Med Rep. 2016. PMID: 27035767 Free PMC article.
-
Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.Cell Physiol Biochem. 2016;39(1):47-60. doi: 10.1159/000445604. Epub 2016 Jun 20. Cell Physiol Biochem. 2016. PMID: 27322513
-
Mechanism of action of Profilin-1 and Fibulin-3 in vascular remodeling in hypertensive rats.Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):8101-8108. doi: 10.26355/eurrev_201909_19028. Eur Rev Med Pharmacol Sci. 2019. PMID: 31599437
-
Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats.Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H25-35. doi: 10.1152/ajpheart.00620.2009. Epub 2010 Apr 9. Am J Physiol Heart Circ Physiol. 2010. PMID: 20382857 Free PMC article.
-
Metalloproteinases (MMPs) in hypertensive disorders: role, function, pharmacology, and potential strategies to mitigate pathophysiological changes.Front Pharmacol. 2025 May 26;16:1559288. doi: 10.3389/fphar.2025.1559288. eCollection 2025. Front Pharmacol. 2025. PMID: 40492135 Free PMC article. Review.
Cited by
-
Chronic Administration of Red Yeast Rice Mitigates Endothelial Dysfunction in Spontaneously Hypertensive Rats by Inhibiting Oxidative Stress and Endothelial Nitric Oxide Synthase Uncoupling.Curr Vasc Pharmacol. 2024;22(5):355-364. doi: 10.2174/0115701611295900240529104225. Curr Vasc Pharmacol. 2024. PMID: 38847159
-
Glucocorticoids Regulate the Vascular Remodeling of Aortic Dissection Via the p38 MAPK-HSP27 Pathway Mediated by Soluble TNF-RII.EBioMedicine. 2018 Jan;27:247-257. doi: 10.1016/j.ebiom.2017.12.002. Epub 2017 Dec 6. EBioMedicine. 2018. PMID: 29287621 Free PMC article.
-
A systematic, updated review of Xuezhikang, a domestically developed lipid-lowering drug, in the application of cardiovascular diseases.Acta Pharm Sin B. 2024 Oct;14(10):4228-4242. doi: 10.1016/j.apsb.2024.05.011. Epub 2024 May 11. Acta Pharm Sin B. 2024. PMID: 39525586 Free PMC article. Review.
-
Traditional Chinese medicines in the management of cardiovascular diseases: a comprehensive systematic review.Br J Clin Pharmacol. 2017 Jan;83(1):20-32. doi: 10.1111/bcp.13013. Epub 2016 Jun 17. Br J Clin Pharmacol. 2017. PMID: 27195823 Free PMC article.
-
Fibulin-3 may improve vascular health through inhibition of MMP-2/9 and oxidative stress in spontaneously hypertensive rats.Mol Med Rep. 2016 May;13(5):3805-12. doi: 10.3892/mmr.2016.5036. Epub 2016 Mar 21. Mol Med Rep. 2016. PMID: 27035767 Free PMC article.
References
-
- Kobayashi N, Kostka G, Garbe JH, Keene DR, Bachinger HP, Hanisch FG, Markova D, Tsuda T, Timpl R, Chu ML, Sasaki T. A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization. J Biol Chem. 2007;282:11805–11816. - PubMed
-
- Huawei P, Qian C, Chuan T, Lei L, Laing W, Wenlong X, Wenzhi L. Decreased expression of fibulin-4 in aortic wall of aortic dissection. Vascular. 2014;22:35–41. - PubMed
-
- Bergers G, Coussens LM. Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr Opin Genet Dev. 2000;10:120–127. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous